Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.
about
Myocilin, a glaucoma-associated protein, promotes cell migration through activation of integrin-focal adhesion kinase-serine/threonine kinase signaling pathwayMyocilin mediates myelination in the peripheral nervous system through ErbB2/3 signalingOlfactomedin 2: expression in the eye and interaction with other olfactomedin domain-containing proteinsOlfactomedin 4 down-regulates innate immunity against Helicobacter pylori infectionDeletion of olfactomedin 2 induces changes in the AMPA receptor complex and impairs visual, olfactory, and motor functions in miceMolecular Details of Olfactomedin Domains Provide Pathway to Structure-Function StudiesStructural basis of latrophilin-FLRT interactionMyocilin interacts with syntrophins and is member of dystrophin-associated protein complexOlfactomedin 1 interacts with the Nogo A receptor complex to regulate axon growth.Structural and Mechanistic Insights into the Latrophilin3-FLRT3 Complex that Mediates Glutamatergic Synapse DevelopmentThe glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequenceOlfactomedin 1 Deficiency Leads to Defective Olfaction and Impaired Female FertilityThe olfactomedin domain from gliomedin is a β-propeller with unique structural properties.Deletion in the N-terminal half of olfactomedin 1 modifies its interaction with synaptic proteins and causes brain dystrophy and abnormal behavior in mice.Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart.Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucoma.Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.Expression of myocilin mutants sensitizes cells to oxidative stress-induced apoptosis: implication for glaucoma pathogenesisSerial analysis of gene expression in the chicken otocyst.Cytokine-induced tumor suppressors: a GRIM storyThe latrophilins, "split-personality" receptors.Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer.Ligands for glaucoma-associated myocilin discovered by a generic binding assayStructural basis for misfolding in myocilin-associated glaucoma.Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semenNotch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320Wnt activation downregulates olfactomedin-1 in Fallopian tubal epithelial cells: a microenvironment predisposed to tubal ectopic pregnancy.Comparative proteomic analysis of egg white proteins during the rapid embryonic growth period by combinatorial peptide ligand libraries.The Olfactory Transcriptome and Progression of Sexual Maturation in Homing Chum Salmon Oncorhynchus ketaThe Evolution of the Scavenger Receptor Cysteine-Rich Domain of the Class A Scavenger Receptors.Amyloid fibril formation by the glaucoma-associated olfactomedin domain of myocilin.Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in miceRNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma.The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.The effect of environmental enrichment on substantia nigra gene expression after traumatic brain injury in rats.Olfactomedin-like 3 (OLFML3) gene expression in baboon and human ocular tissues: cornea, lens, uvea, and retina.Loss of OLFM4 promotes tumor migration through inducing interleukin-8 expression and predicts lymph node metastasis in early gastric cancerOlfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease.
P2860
Q24306176-E82B712B-A229-484C-BFAA-E9266C40AA88Q24313038-A3B4C9A9-73DD-4B66-AD78-5741D5F6351EQ24336787-3E93EEF1-1417-460A-A1DE-57F7189BC864Q28512523-8098C7BB-FEED-422D-9325-31261586F2EDQ28513407-556B1F81-B72F-4A1D-9211-AAAAC9903723Q28545946-C096FBC5-0BD2-48C7-B5DF-7FD20BFAA70FQ28585333-EABDC65D-F8CF-4952-9B5F-B3CF9959435DQ28586144-F7DDAB49-C13F-4925-9DD8-369D35FA6F0BQ28587929-A7B4B78E-9CC0-4E75-874C-C244EFDA2F27Q28592150-91D255AA-919F-4802-93DB-921C5E6ECCFBQ30356731-32572E5E-43F6-41D6-9DA8-EDFCA305D3DCQ30356786-4C50EB5D-096E-459E-AE61-B0DE3BADB588Q30369977-8020CF2F-3B88-44D7-AFDE-1B0AAED00808Q30409264-56E1C149-090A-4EA2-9763-A83811F7DF45Q30539142-FC5A22B1-87F7-407F-A64E-A556BCD7AC73Q33808845-CBA664CD-527C-48C4-AD4A-DA0F60C17601Q33869299-40C86663-87D8-401E-9F67-C8C315FFB29EQ33882506-6357A663-9CE0-4301-879B-ECC63F36D1EFQ33997378-4DE879D5-80DB-4E94-A378-78E66688F12BQ34077445-208AC277-66D8-4764-A9D8-3CF7DE55468CQ34187817-5B1431CB-5363-4544-B338-4609C69BC464Q34450695-BCE1EF26-0F9C-4553-B9CB-9971D6B5E45BQ35000190-D5FC67D4-A1C5-4D3A-AA3F-94B79896B392Q35054336-BF79032F-B0EC-41C4-AC17-29A9EE9E1937Q35234066-D3F3DCB3-F0D6-419A-AC65-88223B79D1FBQ35534585-6831612E-BB02-4D0D-A0EF-06DF074B4BBDQ35655623-0A2437DC-B1ED-4965-A885-C034A1781EEAQ35729814-1DD3F157-7565-4368-B1F6-2A273FA15B9BQ35738031-488E5C77-2B57-4064-9B75-9DABF04D69B3Q35761886-52810595-41B8-4CC4-86DA-7A7DFE0A3263Q35784667-F69B1913-9D7A-4CC2-A257-A0CF549DD269Q35818249-33722F5C-7CDA-45E6-9A46-434C4C457DABQ35881767-7BA706DC-DFBB-4E2C-BECE-E457487778CAQ36179723-1589946D-F6A4-4513-96C0-8687EEB40138Q36299777-AFACB0AD-F7E7-4193-B3F0-8AC71FF9C365Q36481734-4836FC60-97E1-4A3A-B743-00464EAC89A7Q36629436-727142A7-70FA-49E5-A2D4-D219D0D3A453Q36836940-BCA921AB-D1EE-42E9-BE0B-394A1D283E90Q37096228-5F4E1458-96B4-4248-9AE6-4E682ECAA5FDQ37123905-8FF281F9-9C1F-4D66-BB5A-BDE4290C764F
P2860
Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Olfactomedin domain-containing ...... mal development and pathology.
@ast
Olfactomedin domain-containing ...... mal development and pathology.
@en
Olfactomedin domain-containing ...... mal development and pathology.
@nl
type
label
Olfactomedin domain-containing ...... mal development and pathology.
@ast
Olfactomedin domain-containing ...... mal development and pathology.
@en
Olfactomedin domain-containing ...... mal development and pathology.
@nl
prefLabel
Olfactomedin domain-containing ...... mal development and pathology.
@ast
Olfactomedin domain-containing ...... mal development and pathology.
@en
Olfactomedin domain-containing ...... mal development and pathology.
@nl
P2860
P1476
Olfactomedin domain-containing ...... mal development and pathology.
@en
P2093
Naoki Nakaya
Stanislav I Tomarev
P2860
P2888
P304
P356
10.1007/S12035-009-8076-X
P577
2009-06-26T00:00:00Z
P5875
P6179
1047549375